Thursday, 29 January 2015

Genes to Mechanisms and Therapeutic Strategies

Professor John Todd, Professor of Medical Genetics, Cambridge University, will be visiting the Institute of Genetic Medicine (IGM) on Friday 13th February 2015 and will give a lecture on:

"Genes to mechanisms and therapeutic strategies"

The lecture will take place in the West Wing Lecture Theatre at 4.00pm. All welcome.


Brief Biography:

John Todd FRS, FMedSci, FRCP Hons, PhD is Professor of Medical Genetics at Cambridge University, Director of the JDRF/Wellcome Trust Diabetes and Inflammation Laboratory (DIL) in the University's Cambridge Institute for Medical Research and a Senior Investigator of the National Institute for Health Research. Todd researches type 1 diabetes (T1D) genetics and disease mechanisms with an aim of clinical intervention. Previously, Todd was Professor of Human Genetics at Oxford University and a Wellcome Trust Principal Research Fellow. Todd helped pioneer genome-wide genetic studies, first in mice and then in humans. He then went on to study the associations between mapped genomic disease-associated regions and phenotypes by founding and deploying the Cambridge BioResource. His research in genetics and diabetes has received several awards and prizes.

In the latest phase of his research, to translate basic genetic and immunological knowledge to treatment and prevention, the DIL has now completed its first mechanistic, statistically adaptive, drug dose-finding trial in T1D patients, establishing new and effective methods of trial design, governance, conduct and patient recruitment. The DIL has a major role in training and mentoring others in patient/people-based research, promoting data/sample access and sharing, and can advise other laboratories and industrial partners in immunotherapeutics and experimental medicine.

No comments:

Post a comment

Note: only a member of this blog may post a comment.